Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
4.580
-0.060 (-1.29%)
At close: Jun 26, 2026, 4:00 PM EDT
4.640
+0.060 (1.31%)
After-hours: Jun 26, 2026, 5:05 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $110.65 million as of June 26, 2026. Its market cap has decreased by -30.26% in one year.
Market Cap
110.65M
Enterprise Value
116.29M
1-Year Change
-30.26%
Ranking
Category
Stock Price
$4.58
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $110.65M, an increase of 75.34%. That is a compound annual growth rate of 8.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 110.65M | -19.70% |
| Dec 31, 2025 | 137.79M | 90.55% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Personalis | 1.32B |
| OPKO Health | 1.14B |
| Castle Biosciences | 694.86M |
| Fulgent Genetics | 550.97M |
| Myriad Genetics | 512.85M |
| Biodesix | 202.58M |
| Insight Molecular Diagnostics | 180.50M |
| Burning Rock Biotech | 83.84M |